MENU
Alnylam

Archives: Roundtables

September 24, 2015

2015 Summer RNAi Roundtable Series

We hosted a series of online “RNAi Roundtables” in July, August and September, at which Alnylam scientists and key clinical collaborators reviewed recent progress in many of the company’s development-stage pipeline programs and discussed the related disease areas.

August 21, 2014

2014 Summer RNAi Roundtable Series

We hosted a series of online “RNAi Roundtables” during July and August, at which Alnylam scientists and key clinical collaborators reviewed recent progress from several “Alnylam 5×15” programs and discussed the related disease areas.

August 21, 2014

RNAi Roundtable: ALN-AS1 for the treatment of Hepatic Porphyrias

On August 21, 2014, we hosted an online RNAi Roundtable to review the progress with ALN-AS1 in development for the treatment of hepatic porphyrias.

August 20, 2014

RNAi Roundtable: ALN-AAT for the treatment of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease

On August 20, 2014, we hosted an online RNAi Roundtable to review the progress with ALN-AAT in development for the treatment of alpha-1 antitrypsin deficiency-associated liver disease.

August 14, 2014

RNAi Roundtable: ALN-PCSsc for the Treatment of Hypercholesterolemia

On August 14, 2014, we hosted an online RNAi Roundtable to review the progress with ALN-PCSsc in development for the treatment of hypercholesterolemia.

August 13, 2014

RNAi Roundtable: ALN-CC5 for the treatment of Complement-Mediated Diseases

On August 13, 2014, we hosted an online RNAi Roundtable to review the progress with ALN-CC5 in development for the treatment of Complement-Mediated Diseases.

August 7, 2014

RNAi Roundtable: ALN-AT3 for the treatment of Hemophilia and Rare Bleeding Disorders

On August 7, 2014, we hosted an online RNAi Roundtable to review the progress with ALN-AT3 in development for the treatment of Hemophilia and Rare Bleeding Disorders.

July 31, 2014

RNAi Roundtable: ALN-HBV for the treatment of Hepatitis B Virus (HBV) Infection

On July 29, 2014, we hosted an online RNAi Roundtable to review the progress with ALN-HBV in development for the treatment of Hepatitis B Virus (HBV) infection.

July 22, 2014

RNAi Roundtable: Advances in Delivery of RNAi Therapeutics with Enhanced Stabilization Chemistry (ESC)-GalNAc-siRNA Conjugates

On July 22, 2014, we hosted an online RNAi Roundtable to discuss advances in delivery of RNAi therapeutics with Enhanced Stabilization Chemistry (ESC)-GalNAc-siRNA conjugates.

July 15, 2014

RNAi Roundtable: Patisiran and ALN-TTRsc for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis (ATTR)

On July 15, 2014, we hosted an online RNAi Roundtable to review the progress with patisiran and ALN-TTRsc in development for the treatment of Transthyretin (TTR)-Mediated Amyloidosis (ATTR).